CARVEDILOL PHOSPHATE

N/A

Manufactured by Waylis Therapeutics LLC

5,587 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CARVEDILOL PHOSPHATE

CARVEDILOL PHOSPHATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Waylis Therapeutics LLC. The most commonly reported adverse reactions for CARVEDILOL PHOSPHATE include DIZZINESS, FATIGUE, DRUG INEFFECTIVE, DYSPNOEA, NAUSEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CARVEDILOL PHOSPHATE.

Top Adverse Reactions

DIZZINESS308 reports
FATIGUE293 reports
DRUG INEFFECTIVE291 reports
DYSPNOEA191 reports
NAUSEA141 reports
HEADACHE140 reports
BLOOD PRESSURE INCREASED138 reports
DIARRHOEA126 reports
HYPOTENSION119 reports
ASTHENIA109 reports
MALAISE104 reports
FALL92 reports
WEIGHT INCREASED85 reports
FEELING ABNORMAL75 reports
DEATH74 reports
PRURITUS73 reports
HYPERTENSION72 reports
MYOCARDIAL INFARCTION71 reports
PAIN IN EXTREMITY71 reports
PAIN69 reports
INSOMNIA68 reports
PALPITATIONS66 reports
BLOOD PRESSURE DECREASED65 reports
CARDIAC FAILURE CONGESTIVE63 reports
CHEST PAIN62 reports
RASH60 reports
OEDEMA PERIPHERAL57 reports
COUGH56 reports
HEART RATE DECREASED53 reports
ARTHRALGIA52 reports
CEREBROVASCULAR ACCIDENT51 reports
HEART RATE INCREASED51 reports
SOMNOLENCE51 reports
DRUG DOSE OMISSION50 reports
PRODUCT QUALITY ISSUE50 reports
HYPOAESTHESIA49 reports
LOSS OF CONSCIOUSNESS49 reports
MUSCLE SPASMS49 reports
VISION BLURRED48 reports
ABDOMINAL DISCOMFORT45 reports
WEIGHT DECREASED45 reports
BLOOD GLUCOSE INCREASED44 reports
CONSTIPATION44 reports
GAIT DISTURBANCE43 reports
VOMITING43 reports
ALOPECIA42 reports
ANXIETY42 reports
CARDIAC DISORDER41 reports
HYPERHIDROSIS41 reports
PARAESTHESIA41 reports
BACK PAIN40 reports
CHEST DISCOMFORT40 reports
DECREASED APPETITE38 reports
RENAL FAILURE37 reports
OFF LABEL USE36 reports
ATRIAL FIBRILLATION35 reports
DEPRESSION35 reports
PNEUMONIA35 reports
PRODUCT SUBSTITUTION ISSUE35 reports
ARRHYTHMIA34 reports
ILL DEFINED DISORDER34 reports
ABDOMINAL PAIN UPPER33 reports
ADVERSE EVENT32 reports
MYALGIA32 reports
ABDOMINAL DISTENSION31 reports
BLOOD PRESSURE FLUCTUATION31 reports
HEART RATE IRREGULAR31 reports
ABDOMINAL PAIN30 reports
OVERDOSE30 reports
BALANCE DISORDER29 reports
JOINT SWELLING29 reports
MUSCULAR WEAKNESS29 reports
ADVERSE DRUG REACTION28 reports
ANAEMIA28 reports
ERYTHEMA28 reports
FEELING HOT28 reports
FLUSHING28 reports
HOSPITALISATION28 reports
TREMOR28 reports
OEDEMA27 reports
SYNCOPE26 reports
VISUAL IMPAIRMENT26 reports
BLOOD PRESSURE INADEQUATELY CONTROLLED25 reports
CONDITION AGGRAVATED25 reports
HYPERSENSITIVITY25 reports
MEMORY IMPAIRMENT25 reports
CONFUSIONAL STATE24 reports
CONTUSION24 reports
DRY MOUTH23 reports
EJECTION FRACTION DECREASED23 reports
SINUSITIS23 reports
SWELLING23 reports
DRUG HYPERSENSITIVITY22 reports
DYSPEPSIA22 reports
GASTROINTESTINAL HAEMORRHAGE22 reports
PERIPHERAL SWELLING22 reports
RHINORRHOEA22 reports
CARDIAC FAILURE21 reports
DRUG INTERACTION21 reports
FLUID RETENTION21 reports

Report Outcomes

Out of 2,953 classified reports for CARVEDILOL PHOSPHATE:

Serious 37.7%Non-Serious 62.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female1,481 (55.1%)
Male1,203 (44.8%)
Unknown2 (0.1%)

Reports by Age

Age 6358 reports
Age 7354 reports
Age 6953 reports
Age 7053 reports
Age 6151 reports
Age 7451 reports
Age 6650 reports
Age 6548 reports
Age 6047 reports
Age 6747 reports
Age 7947 reports
Age 8047 reports
Age 6446 reports
Age 6846 reports
Age 6244 reports
Age 7644 reports
Age 7243 reports
Age 5542 reports
Age 5939 reports
Age 7139 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CARVEDILOL PHOSPHATE?

This profile reflects 5,587 FDA FAERS reports that mention CARVEDILOL PHOSPHATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CARVEDILOL PHOSPHATE?

Frequently reported terms in FAERS include DIZZINESS, FATIGUE, DRUG INEFFECTIVE, DYSPNOEA, NAUSEA, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CARVEDILOL PHOSPHATE?

Labeling and FAERS entries often list Waylis Therapeutics LLC in connection with CARVEDILOL PHOSPHATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.